
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
ED-71 inhibited osteoclastogenesis by enhancing EphrinB2–EphB4 signaling between osteoclasts and osteoblasts in osteoporosis
Yuan Zhang, Yuying Kou, Panpan Yang, et al.
Cellular Signalling (2022) Vol. 96, pp. 110376-110376
Closed Access | Times Cited: 16
Yuan Zhang, Yuying Kou, Panpan Yang, et al.
Cellular Signalling (2022) Vol. 96, pp. 110376-110376
Closed Access | Times Cited: 16
Showing 16 citing articles:
Eldecalcitol prevented OVX-induced osteoporosis through inhibiting BMSCs senescence by regulating the SIRT1-Nrf2 signal
Yuying Kou, Xing Rong, Rong Tang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
Yuying Kou, Xing Rong, Rong Tang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
ED-71 ameliorates OVX-induced osteoporosis by regulating calcium homeostasis and SIRT1-mediated mitochondrial function, alleviating osteoblast senescence and suppressing osteoclastogenesis
Yaoguang Zhang, Yajun Cui, Changyun Sun, et al.
Cellular Signalling (2025), pp. 111713-111713
Closed Access
Yaoguang Zhang, Yajun Cui, Changyun Sun, et al.
Cellular Signalling (2025), pp. 111713-111713
Closed Access
ED-71 Prevents Glucocorticoid-Induced Osteoporosis by Regulating Osteoblast Differentiation via Notch and Wnt/β-Catenin Pathways
Xing Rong, Yuying Kou, Yuan Zhang, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 3929-3946
Open Access | Times Cited: 19
Xing Rong, Yuying Kou, Yuan Zhang, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 3929-3946
Open Access | Times Cited: 19
Imbalanced EphB4/EphrinB2 Signaling Modulates Bone Resorption in Periodontitis Induced by Porphyromonas gingivalis
Ying Fu, Shuwei Zhang, Junchao Liu, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 4, pp. 1152-1161
Closed Access | Times Cited: 3
Ying Fu, Shuwei Zhang, Junchao Liu, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 4, pp. 1152-1161
Closed Access | Times Cited: 3
Regulation of bone homeostasis: signaling pathways and therapeutic targets
Zebin Wu, Wenming Li, Kunlong Jiang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 3
Zebin Wu, Wenming Li, Kunlong Jiang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 3
Bone‐Targeting and Multishelled Oral Eldecalcitol Nanoparticles Improve Osteoporosis by Reconstruction of Osteogenic‐Osteoclastic Homeostasis
Lingxiao Meng, Wanli Ma, Yuping Jiang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 44
Closed Access | Times Cited: 2
Lingxiao Meng, Wanli Ma, Yuping Jiang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 44
Closed Access | Times Cited: 2
The nano-artificial periosteum made of PCL/MgO/AS-IV enhances MC3T3-E1 cell osteogenic differentiation and promotes bone defect repair via the EphB4/EphrinB2 signaling pathway
Wei Wang, Dan-Fang Sun, Huixia Cui, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e32036-e32036
Open Access | Times Cited: 1
Wei Wang, Dan-Fang Sun, Huixia Cui, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e32036-e32036
Open Access | Times Cited: 1
ED-71 Improves Bone Mass in Ovariectomized Rats by Inhibiting Osteoclastogenesis Through EphrinB2-EphB4-RANKL/OPG Axis
Wang Ke, Yuying Kou, Xing Rong, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 1515-1528
Open Access
Wang Ke, Yuying Kou, Xing Rong, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 1515-1528
Open Access
Identification of potential pathogenic genes related to osteoporosis and osteoarthritis
Zhanchao Wang, Wei Wang, Bin Zuo, et al.
Technology and Health Care (2024) Vol. 32, Iss. 6, pp. 4431-4444
Open Access
Zhanchao Wang, Wei Wang, Bin Zuo, et al.
Technology and Health Care (2024) Vol. 32, Iss. 6, pp. 4431-4444
Open Access
Osteogenic CpG oligodeoxynucleotide, iSN40, inhibits osteoclastogenesis in a TLR9-dependent manner
R. Ikeda, Chihaya Kimura, Yuma Nihashi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
R. Ikeda, Chihaya Kimura, Yuma Nihashi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Eldecalcitol ameliorates diabetic osteoporosis and glucolipid metabolic disorder by promoting Treg cell differentiation through SOCE
Yujun Jiang, Ruihan Gao, Qiaohui Ying, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access
Yujun Jiang, Ruihan Gao, Qiaohui Ying, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access
ED-71 promotes osseointegration of titanium implants in a rat model of GIOP by alleviating the effects of dexamethasone on bone remodeling in a SIRT1-dependent manner
Chunying Li, Pengfei Xue, Guanglin Duan, et al.
Journal of Oral Biosciences (2024), pp. 100571-100571
Closed Access
Chunying Li, Pengfei Xue, Guanglin Duan, et al.
Journal of Oral Biosciences (2024), pp. 100571-100571
Closed Access
Osteogenic CpG Oligodeoxynucleotide, iSN40, Inhibits Osteoclastogenesis in a TLR9-Dependent Manner
R. Ikeda, Chihaya Kimura, Yuma Nihashi, et al.
Life (2024) Vol. 14, Iss. 12, pp. 1572-1572
Open Access
R. Ikeda, Chihaya Kimura, Yuma Nihashi, et al.
Life (2024) Vol. 14, Iss. 12, pp. 1572-1572
Open Access
Yi Shen Juan Bi Pill alleviates bone destruction in inflammatory arthritis under postmenopausal conditions by regulating ephrinB2 signaling
Huihui Xu, Tao Li, Jinfeng Cao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 1
Huihui Xu, Tao Li, Jinfeng Cao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 1
Evaluation of Biological Mechanisms of Quanduzhong Capsule for Treating Osteoporosis by Integrating Untargeted Metabolomics and Network Pharmacology
Fangfang Yu, Leyi Huang, Manman Li, et al.
Pharmaceutical Fronts (2023) Vol. 05, Iss. 03, pp. e197-e208
Open Access
Fangfang Yu, Leyi Huang, Manman Li, et al.
Pharmaceutical Fronts (2023) Vol. 05, Iss. 03, pp. e197-e208
Open Access
Vitamin D and Immune System: Implications in Bone Health
Asha Bhardwaj, Tamanna Sharma, Sneha Das, et al.
BENTHAM SCIENCE PUBLISHERS eBooks (2023), pp. 46-74
Closed Access
Asha Bhardwaj, Tamanna Sharma, Sneha Das, et al.
BENTHAM SCIENCE PUBLISHERS eBooks (2023), pp. 46-74
Closed Access
Treatment for Gorham-Stout syndrome with a combination of teriparatide and denosumab
Liqin Zhang, Weihong Wang, Liang Wen, et al.
Osteoporosis International (2023) Vol. 35, Iss. 4, pp. 727-731
Closed Access
Liqin Zhang, Weihong Wang, Liang Wen, et al.
Osteoporosis International (2023) Vol. 35, Iss. 4, pp. 727-731
Closed Access